logo
Share SHARE
FONT-SIZE Plus   Neg

Perrigo: FDA Oks Hydrocodone Bitartrate &Homatropine Methylbromide Oral Solution

Perrigo Company plc (PRGO) today announced it has received final approval from the U.S. Food and Drug Administration for hydrocodone bitartrate and homatropine methylbromide oral solution (syrup), 5 mg/1.5 mg per 5 mL.

Hydrocodone bitartrate and homatropine methylbromide oral solution (syrup), 5 mg/1.5 mg per 5 mL is indicated for the symptomatic relief of cough in adults and children 6 years of age and older. Annual sales for the 12 months ending January 2017 were about $16 million.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Employees at Bombardier Inc.'s aerospace plant in Toronto plan to walk out of the facility on Wednesday morning. The move is an attempt to put pressure on Boeing Co. to drop a trade complaint against the Canadian plane and train maker. The Baltimore Ravens, a professional American football team, postponed its "DNA Day" event just hours before this season's home opener last Sunday. Orig3n Inc., a Boston-based biotech company sponsoring the event, said in a statement that it is "working to address questions from officials from the state of Maryland." A new analysis selects Alaska Airlines as the best domestic airline for Elite Status. According to credit-card rewards website The Points Guy, Alaska offers the best perks to its frequent flyers under airline loyalty program, beating out those offered by five competing domestic companies.
comments powered by Disqus
Follow RTT